General MedicationsINJECTIONStandard
KETALAR
KETAMINE HYDROCHLORIDE
Standard Dose
EQ 50MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview KETALAR is listed in Drugs@FDA under application 016812 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient KETAMINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 50MG BASE/ML Sponsor PH HEALTH Submission history Latest submission status date: 2026-03-23 00:00:00.
Structured Monograph
Clinical summary
Approval overview KETALAR is listed in Drugs@FDA under application 016812 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient KETAMINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 50MG BASE/ML Sponsor PH HEALTH Submission history Latest submission status date: 2026-03-23 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.